Remarkably, we found that OIM induced a significant increase in DHS at the promoter of DKK1, a known competitive inhibitor of the WNT pathway whose expression is linked to osteopenia and bone metastasis [39], [40]. The gene discussed is DKK1; the disease is Osteopenia.